本頁面由Tiger Trade Technology Pte. Ltd.提供服務

窺得兒醫藥

11.18
-0.6000-5.09%
成交量:120.19萬
成交額:1,388.02萬
市值:7.67億
市盈率:-0.73
高:11.88
開:11.71
低:11.18
收:11.78
52周最高:35.58
52周最低:9.92
股本:6,857.54萬
流通股本:6,116.90萬
量比:1.67
換手率:1.96%
股息:- -
股息率:- -
每股收益(TTM):-15.3950
每股收益(LYR):-16.6932
淨資產收益率:-45.91%
總資產收益率:0.38%
市淨率:0.43
市盈率(LYR):-0.67

資料載入中...

2023/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2022/05/27

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/05/16

重要事件披露

8-K - Current report
2022/05/06

重要事件披露

8-K - Current report
2022/05/06

企業合併公告

425 - Prospectuses and communications, business combinations
2022/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

企業合併公告

425 - Prospectuses and communications, business combinations
2022/05/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/04

企業合併公告

425 - Prospectuses and communications, business combinations
2022/05/04

重要事件披露

8-K - Current report
2022/04/07

重要事件披露

8-K - Current report
2022/03/11

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/18

企業合併公告

425 - Prospectuses and communications, business combinations
2022/02/18

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/17

重要事件披露

8-K - Current report
2022/02/17

企業合併公告

425 - Prospectuses and communications, business combinations
2022/02/14

重要事件披露

8-K - Current report
2022/02/14

企業合併公告

425 - Prospectuses and communications, business combinations
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals